Charles River Laboratories International, Inc. News Headlines

CRL 
$63.59
*  
0.33
0.52%
Get CRL Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Progenics' Loss Narrows Y/Y - Analyst Blog
8/15/2013 8:31:16 AM - Zacks.com


Salix Misses on 2Q Earnings - Analyst Blog
8/14/2013 10:20:01 AM - Zacks.com


AVEO Pharma Cuts Q2 Loss - Analyst Blog
8/14/2013 8:55:52 AM - Zacks.com


Pharma And Biotechs Offer Rewards And Risk - Which Will You Choose?
8/12/2013 10:04:00 AM - Seeking Alpha


In Line Loss at Orexigen in Q2 - Analyst Blog
8/7/2013 9:41:44 AM - Zacks.com


Label Expansion for Novartis' Menveo - Analyst Blog
8/5/2013 3:40:15 PM - Zacks.com


ABCO Misses Q1 Earnings, Beats Rev - Analyst Blog
8/5/2013 12:40:15 PM - Zacks.com


Charles River Beats on Earnings in Q2 - Analyst Blog
8/1/2013 4:07:50 PM - Zacks.com


Loss Narrows at Dynavax in Q2 - Analyst Blog
7/31/2013 10:21:11 AM - Zacks.com


Good News for BMY/AZN on Dapagliflozin - Analyst Blog
7/29/2013 5:29:01 PM - Zacks.com


Will Merck (MRK) Beat Earnings This Quarter? - Analyst Blog
7/29/2013 2:29:01 PM - Zacks.com


Merck's Vorapaxar NDA Accepted - Analyst Blog
7/25/2013 5:58:09 PM - Zacks.com


Chelsea's NDA for Northera Accepted - Analyst Blog
7/19/2013 4:21:50 PM - Zacks.com


Northera NDA Resubmitted By Chelsea - Analyst Blog
7/11/2013 5:56:18 PM - Zacks.com


Salix Achieves 52-Week High - Analyst Blog
7/9/2013 3:45:01 PM - Zacks.com


Bayer Announces Positive Phase I Data - Analyst Blog
7/8/2013 4:00:01 PM - Zacks.com


Bayer Progresses with its Cancer Drugs - Analyst Blog
7/5/2013 3:30:01 PM - Zacks.com


Yet Another Setback for Bayer/JNJ's Xarelto - Analyst Blog
7/2/2013 4:27:01 PM - Zacks.com


CRL for Merck's Suvorexant - Analyst Blog
7/2/2013 3:37:49 PM - Zacks.com


Charles River Laboratories: Why Bulls Should Be Worried
7/2/2013 3:30:00 PM - Seeking Alpha


Astellas/Toa Eiyo's Bisono Tape OK'd - Analyst Blog
7/1/2013 3:30:01 PM - Zacks.com


New Data on Novo Nordisk's Tresiba - Analyst Blog
6/24/2013 5:20:01 PM - Zacks.com


Charles River Labortories: A Leading Rat Supplier
6/24/2013 4:39:00 PM - Seeking Alpha


MannKind Completes Afrezza Studies - Analyst Blog
6/18/2013 2:30:01 PM - Zacks.com


Label Expansion for Astellas Drug - Analyst Blog
6/17/2013 4:31:56 PM - Zacks.com